{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:24:27Z","timestamp":1783344267201,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T00:00:00Z","timestamp":1507680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ekir.2017.10.005","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T02:00:59Z","timestamp":1508119259000},"page":"302-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Complement Activation in Patients With Diabetic Nephropathy"],"prefix":"10.1016","volume":"3","author":[{"given":"Pascal","family":"Bus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie S.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line Q.F.","family":"Klessens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malu","family":"Zandbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Wolterbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees","family":"van Kooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leendert A.","family":"Trouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Bruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Baelde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2017.10.005_bib1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/BF00284458","article-title":"Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study","volume":"25","author":"Andersen","year":"1983","journal-title":"Diabetologia"},{"key":"10.1016\/j.ekir.2017.10.005_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","article-title":"Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)","volume":"63","author":"Adler","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2017.10.005_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1464-5491.2004.01390.x","article-title":"Unchanged incidence of diabetic nephropathy in type 1 diabetes: a nation-wide study in Iceland","volume":"22","author":"Tryggvason","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.ekir.2017.10.005_bib4","doi-asserted-by":"crossref","first-page":"i6505","DOI":"10.1136\/bmj.i6505","article-title":"How to prevent the microvascular complications of type 2 diabetes beyond glucose control","volume":"356","author":"Valencia","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.ekir.2017.10.005_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2017.10.005_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1210\/er.2003-0018","article-title":"From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors\/cytokines","volume":"25","author":"Schrijvers","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ekir.2017.10.005_bib7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1210\/er.2014-1099","article-title":"Role of complement and complement regulatory proteins in the complications of diabetes","volume":"36","author":"Ghosh","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ekir.2017.10.005_bib8","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.2337\/db10-1181","article-title":"Transcriptome analysis of human diabetic kidney disease","volume":"60","author":"Woroniecka","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.ekir.2017.10.005_bib9","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1172\/JCI36150","article-title":"Macrophage diversity in renal injury and repair","volume":"118","author":"Ricardo","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2017.10.005_bib10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1172\/JCI111004","article-title":"Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease","volume":"72","author":"Falk","year":"1983","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2017.10.005_bib11","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2337\/diabetes.53.10.2653","article-title":"Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes","volume":"53","author":"Qin","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.ekir.2017.10.005_bib12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/ki.1991.326","article-title":"Measurement of SC5b-9 in urine in patients with the nephrotic syndrome","volume":"40","author":"Ogrodowski","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2017.10.005_bib13","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1681\/ASN.V114700","article-title":"Complement activation products in the urine from proteinuric patients","volume":"11","author":"Morita","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.10.005_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneph.2017.31","article-title":"The role of the complement system in diabetic nephropathy","volume":"13","author":"Flyvbjerg","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2017.10.005_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s00125-004-1594-1","article-title":"Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy","volume":"48","author":"Saraheimo","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.ekir.2017.10.005_bib16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/acs.biochem.5b00777","article-title":"Identification of C1q as a binding protein for advanced glycation end products","volume":"55","author":"Chikazawa","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.ekir.2017.10.005_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000371426","article-title":"Renal C3 complement component: feed forward to diabetic kidney disease","volume":"41","author":"Kelly","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2017.10.005_bib18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ajh.23478","article-title":"A\u00a0specific and sensitive assay for blood levels of glycated CD59: a novel biomarker for diabetes","volume":"88","author":"Ghosh","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ekir.2017.10.005_bib19","doi-asserted-by":"crossref","first-page":"e113639","DOI":"10.1371\/journal.pone.0113639","article-title":"C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-beta\/smad3 and IKBalpha pathway","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2017.10.005_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.kint.2016.01.023","article-title":"An autopsy study suggests that diabetic nephropathy is underdiagnosed","volume":"90","author":"Klessens","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2017.10.005_bib21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy","volume":"21","author":"Tervaert","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.10.005_bib22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/ki.2011.497","article-title":"Pros and cons for C4d as a biomarker","volume":"81","author":"Cohen","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2017.10.005_bib23","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.2337\/dc13-0203","article-title":"Increased complement activation in human type 1 diabetes pancreata","volume":"36","author":"Rowe","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ekir.2017.10.005_bib24","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1046\/j.1523-1755.2002.00384.x","article-title":"Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy","volume":"61","author":"Paueksakon","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2017.10.005_bib25","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1681\/ASN.2014050429","article-title":"Complement factor C4d is a common denominator in thrombotic microangiopathy","volume":"26","author":"Chua","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.10.005_bib26","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/01.RES.43.5.738","article-title":"The distribution of blood rheological parameters in the microvasculature of cat mesentery","volume":"43","author":"Lipowsky","year":"1978","journal-title":"Circ Res"},{"key":"10.1016\/j.ekir.2017.10.005_bib27","first-page":"9","article-title":"Vascular wall shear stress: basic principles and methods","volume":"46","author":"Papaioannou","year":"2005","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.ekir.2017.10.005_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.mnh.0000199011.41552.de","article-title":"Systolic blood pressure as the trigger for the renal myogenic response: protective or autoregulatory?","volume":"15","author":"Loutzenhiser","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ekir.2017.10.005_bib29","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/sj.bjp.0702739","article-title":"Role of shear stress in nitric oxide-dependent modulation of renal angiotensin II vasoconstriction","volume":"127","author":"Endlich","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ekir.2017.10.005_bib30","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.ophtha.2016.02.018","article-title":"Manifestations of complement-mediated and immune complex-mediated membranoproliferative glomerulonephritis: a comparative consecutive series","volume":"123","author":"Dalvin","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ekir.2017.10.005_bib31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/ajkd.2002.31988","article-title":"Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies","volume":"39","author":"Mazzucco","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2017.10.005_bib32","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.2337\/diabetes.48.7.1454","article-title":"Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study","volume":"48","author":"Orchard","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.ekir.2017.10.005_bib33","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.ekir.2017.10.005_bib34","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1073\/pnas.80.9.2757","article-title":"Nonenzymatic glucosylation of homologous low density lipoprotein and albumin renders them immunogenic in the guinea pig","volume":"80","author":"Witztum","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ekir.2017.10.005_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01322339","article-title":"Troponin subunits contribute to altered myosin ATPase activity in diabetic cardiomyopathy","volume":"151","author":"Malhotra","year":"1995","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ekir.2017.10.005_bib36","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/dmrr.1079","article-title":"Binding of mannose-binding lectin to fructosamines: a potential link between hyperglycaemia and complement activation in diabetes","volume":"26","author":"Fortpied","year":"2010","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.ekir.2017.10.005_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1681\/ASN.2012020187","article-title":"IgM contributes to glomerular injury in FSGS","volume":"24","author":"Strassheim","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.10.005_bib38","doi-asserted-by":"crossref","first-page":"F932","DOI":"10.1152\/ajprenal.00509.2010","article-title":"Natural IgM antibodies are involved in the activation of complement by hypoxic human tubular cells","volume":"300","author":"van der Pol","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ekir.2017.10.005_bib39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.molimm.2004.07.045","article-title":"The role of IgM antibodies in the recognition and clearance of apoptotic cells","volume":"42","author":"Peng","year":"2005","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ekir.2017.10.005_bib40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10495-006-0581-z","article-title":"Identification of poly-reactive natural IgM antibody that recognizes late apoptotic cells and promotes phagocytosis of the cells","volume":"12","author":"Fu","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.ekir.2017.10.005_bib41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2217\/1750743X.1.2.241","article-title":"Natural human immunoglobulins in cancer immunotherapy","volume":"1","author":"Vollmers","year":"2009","journal-title":"Immunotherapy"},{"key":"10.1016\/j.ekir.2017.10.005_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/HYPERTENSIONAHA.115.05484","article-title":"Classical complement pathway activation in the kidneys of women with preeclampsia","volume":"66","author":"Penning","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.ekir.2017.10.005_bib43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/tri.12936","article-title":"Glomerular C4d deposits can mark structural capillary wall remodelling in thrombotic microangiopathy and transplant glomerulopathy: C4d beyond active antibody-mediated injury: a retrospective study","volume":"30","author":"Gasim","year":"2017","journal-title":"Transpl Int"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024917304230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024917304230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:20:44Z","timestamp":1762831244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024917304230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2468024917304230"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2017.10.005","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement Activation in Patients With Diabetic Nephropathy","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2017.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}